Current Duke Appointments & Affiliations
Adjunct Associate Professor in the Department of Medicine
·
2020 - Present
Medicine, Cardiology,
Medicine
Recent Scholarly Works
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study.
Journal article Eur Heart J · June 23, 2026 BACKGROUND AND AIMS: Aficamten is a next-in-class, oral selective cardiac myosin inhibitor that ameliorates hypercontractility in hypertrophic cardiomyopathy (HCM). This study assessed the safety and efficacy of extended aficamten treatment in symptomatic ... Full text Link to item CiteConcomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Journal article JACC Heart Fail · February 2026 BACKGROUND: Disopyramide, used in obstructive hypertrophic cardiomyopathy (oHCM) for its negative inotropic properties mediated by its reduction in cytosolic calcium, has been recommended for decades as an option to relieve resistant obstruction. Aficamten ... Full text Link to item CiteSafety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM.
Journal article J Card Fail · February 2026 Full text Link to item CiteRecent Grants
PTN2- TO# BPCA Pharmacology Studies
ResearchPanel Member · Awarded by National Institute for Child Health & Human Develo · 2018 - 2023PTN_TO#50 POPS LAB
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2022Heart Failure Network: Year 12 Non-Compete Renewal
Clinical TrialMedical Monitor · Awarded by National Institutes of Health · 2006 - 2021View All Grants
Education
University of Bologna (Italy) ·
1999
M.D.